Rat IEC-6 intestinal epithelial cells and human Caco-2 colon epit

Rat IEC-6 intestinal epithelial cells and human Caco-2 colon epithelial cells (American Type Culture Collection, Manassas, VA) were maintained in Ham’s F-12 medium containing 10% fetal calf serum. The anti-Hu antigen R (HuR), anti-tristetraprolin (TTP), anti-Auf-1, anti-KSRP antibodies, HuR and TTP small interfering RNA (siRNA) and control Tanespimycin solubility dmso siRNA (siScr) were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA). The plasmid construct pcDNA3.1/mHuRcoding-3′ untranslated region (UTR)/Flag contains a wildtype (wt) HuR gene and was a generous gift

from Dr. Beth S. Lee (Ohio State University, Columbus, OH).12 The antihuman ASBT antibody was a generous gift from Dr. Paul Dawson (Wake Forest University School of Medicine, Winston Salem, NC).13 The anti-β-actin antibody was purchased from Sigma (St. Louis, MO). Recombinant plasmids were prepared using standard techniques with details provided in the Supporting Methods. The full-length rat and human ASBT 3′UTR were subcloned into pCRII-TOPO (pCRII-rASBT3′/3.1 and pCRII-hASBT3′/2.1 kb 3′UTR, respectively). Three fragments EGFR inhibitor drugs of the rat ASBT 3′UTR 1155-4270 (3.1 kb, the full 3′UTR region), 2434-4128 (1.7 kb), and 2114-2434 (0.3 kb) (GenBank NM_017222) (Fig. 1) were subcloned into

either a pGL3 vector for luciferase assays or into a β-globin reporter for mRNA half-life determinations. IEC-6 or Caco-2 cells (5 × 105/well) were transfected with 3 μg of the rASBT3′-luciferase construct of interest and 0.1 μg of a quantification

control plasmid pRL-TK containing a thymidine kinase promoter-driven Renilla luciferase gene (Promega, Madison, WI). Transfection and luciferase activity measurements were performed as described.14 Results are expressed as relative light units (RLU), the ratio of firefly to Renilla luciferase activities.15 IEC-6 cells second (5 × 106) were transfected with 30 μg of rASBT3-β-globin hybrid constructs plus or minus 10 μM siHuR for 48 hours before mRNA half-life assays. In addition to withdrawal of serum from the medium, transcription and translation of logarithmically growing cells were terminated by withdrawal of serum and addition of 10 μg/mL actinomycin D and 10 μg/mL cycloheximide. Total cellular RNA was extracted at different times using TRIzol reagent (Invitrogen, Carlsbad, CA). Twenty micrograms of total cellular RNA were analyzed by northern blotting16 with 32P-labeled β-globin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) complementary DNA (cDNA).16, 17 Signal was quantified using a Phosphoimager Molecular Imager FX (Bio-Rad, Hercules, CA). mRNA half-life was determined by linear regression of a natural log transformation against time. The 32P-labeled RNA probes of the 0.3 kb rASBT 3′UTR were synthesized by in vitro transcription of 0.

Comments are closed.